SABMiller Goes Hostile, But Price Set to Rise |
Equity Research & Insights |
Philip Gorham, CFA |
17/08/11 |
Yield Seekers May Still Be Interested in BAT |
Equity Research & Insights |
Philip Gorham, CFA |
29/07/11 |
Non-cigarette Products Come to Imperial's Rescue |
Equity Research & Insights |
Philip Gorham, CFA |
26/07/11 |
Imperial Could be a Winner of Australia's Bill |
Equity Research & Insights |
Philip Gorham, CFA |
06/07/11 |
The Price is Right for BAT's Protabaco Purchase |
Equity Research & Insights |
Philip Gorham, CFA |
26/05/11 |
Diageo's Rumoured Jose Cuervo Deal Makes Sense |
Equity Research & Insights |
Philip Gorham, CFA |
25/05/11 |
The Market is Overlooking SABMiller’s Challenges |
Equity Research & Insights |
Philip Gorham, CFA |
19/05/11 |
Imperial May Become Attractive Acquisition Target |
Equity Research & Insights |
Philip Gorham, CFA |
12/05/11 |
Diageo: A Safe Haven From Cost Inflation? |
Equity Research & Insights |
Philip Gorham, CFA |
05/05/11 |
Improvements for BAT but Better Value Elsewhere? |
Equity Research & Insights |
Philip Gorham, CFA |
28/04/11 |
SABMiller's Momentum Looks Priced In |
Equity Research & Insights |
Philip Gorham, CFA |
19/04/11 |
Tobacco-free Nicotine: No Smoke, No Fire for BAT? |
Equity Research & Insights |
Philip Gorham, CFA |
06/04/11 |
Spot the Clouds on SABMiller's Horizon |
Equity Research & Insights |
Philip Gorham, CFA |
31/03/11 |
We Think the Market is Undervaluing Imperial |
Equity Research & Insights |
Philip Gorham, CFA |
31/03/11 |
The Market Is Missing Imperial Tobacco's Potential |
Equity Research & Insights |
Philip Gorham, CFA |
24/03/11 |
Near-term Headwinds Remain for Sainsbury |
Equity Research & Insights |
Philip Gorham, CFA |
23/03/11 |
Big Tobacco Unlikely to See Menthol Ban in the US |
Equity Research & Insights |
Philip Gorham, CFA |
21/03/11 |
Tobacco Display Ban Likely to Have Minimal Impact |
Equity Research & Insights |
Philip Gorham, CFA |
10/03/11 |
Tobacco Sees a Favourable Report on Menthol Usage |
Equity Research & Insights |
Philip Gorham, CFA |
02/03/11 |
What's Smoking in Big Tobacco? |
Equity Research & Insights |
Philip Gorham, CFA |
24/02/11 |
Diageo Set to Dominate the Turkish Spirits Market |
Equity Research & Insights |
Philip Gorham, CFA |
22/02/11 |
European Hangover for Diageo but GEM Story Intact |
Equity Research & Insights |
Philip Gorham, CFA |
11/02/11 |
Trading Down in EU Markets to Benefit Imperial |
Equity Research & Insights |
Philip Gorham, CFA |
03/02/11 |
The Market Is Overlooking Imperial's Strengths |
Equity Research & Insights |
Philip Gorham, CFA |
03/02/11 |
SABMiller's Growth Prospects Are Fully Priced In |
Equity Research & Insights |
Philip Gorham, CFA |
18/01/11 |
Sainsbury to Face Headwinds After Strong Holidays |
Equity Research & Insights |
Philip Gorham, CFA |
12/01/11 |
Diageo May Still Hold Appeal for Income Seekers |
Equity Research & Insights |
Philip Gorham, CFA |
07/01/11 |
Can SABMiller Step Up its Global Reach? |
Equity Research & Insights |
Philip Gorham, CFA |
04/01/11 |
For Some Smoking Dividend Yields, Look to Tobacco |
Equity Research & Insights |
Philip Gorham, CFA |
15/12/10 |
Critical US Report Unlikely to Hit Big Tobacco |
Equity Research & Insights |
Philip Gorham, CFA |
13/12/10 |
Acquisition Talks Raise Spirits around Diageo |
Equity Research & Insights |
Philip Gorham, CFA |
10/12/10 |
Dichotomy Widens Between SABMiller's Segments |
Equity Research & Insights |
Philip Gorham, CFA |
18/11/10 |
Whiskey or Cognac: What's Diageo's Tipple? |
Equity Research & Insights |
Philip Gorham, CFA |
17/11/10 |
The US FDA Clamps Down on the Tobacco Industry |
Equity Research & Insights |
Philip Gorham, CFA |
11/11/10 |
We See Limited Upside to Imperial Tobacco's Shares |
Equity Research & Insights |
Philip Gorham, CFA |
02/11/10 |
Could BAT's Broad Portfolio Fit All Climates? |
Equity Research & Insights |
Philip Gorham, CFA |
29/10/10 |
Alcohol Producers Have Three Shots for Growth |
Equity Research & Insights |
Philip Gorham, CFA |
25/10/10 |
Europe Soft for Diageo in the First Half |
Equity Research & Insights |
Philip Gorham, CFA |
14/10/10 |
Imperial Should Gain From Soft Consumer Sentiment |
Equity Research & Insights |
Philip Gorham, CFA |
01/09/10 |
A Mixed Cocktail of Results from Diageo |
Equity Research & Insights |
Philip Gorham, CFA |
26/08/10 |
Pricing Boosts British American in 2Q |
Equity Research & Insights |
Philip Gorham, CFA |
28/07/10 |
Big Tobacco Avoids Racketeering Penalty |
Equity Research & Insights |
Philip Gorham, CFA |
29/06/10 |
The Fire is Still Burning at British American |
Equity Research & Insights |
Philip Gorham, CFA |
25/06/10 |
Winners and Losers from Tobacco Regulation |
Equity Research & Insights |
Philip Gorham, CFA |
10/05/10 |
Strong Coffee Sales Boost Nestle in 1Q |
Equity Research & Insights |
Philip Gorham, CFA |
22/04/10 |
Imperial Tobacco Fined for Price-Fixing |
Equity Research & Insights |
Philip Gorham, CFA |
16/04/10 |
Danone's Revenues Struggle to Meet Volumes |
Equity Research & Insights |
Philip Gorham, CFA |
15/04/10 |
Imperial's 1H confirms its ability to outperform |
Equity Research & Insights |
Philip Gorham, CFA |
02/02/10 |
Nestle's sale is a great deal for shareholders |
Equity Research & Insights |
Philip Gorham, CFA |
04/01/10 |
Imperial Tobacco's 2009 confirms our thesis |
Equity Research & Insights |
Philip Gorham, CFA |
10/11/09 |